Martin Pue

Martin Pue is a biochemistry graduate of the University of Birmingham who then received his Ph.D. from the University of London. He has more than 35 years of experience in drug discovery and development in the pharmaceutical industry. Prior to joining Autifony, he was head of project management with Vernalis leading the development, registration, and commercialization of small molecule projects focussed on migraine and Parkinson’s Disease. His early industry career was as drug metabolism and pharmacokinetic scientist with Smith Kline Beecham working in both the UK and USA. He has over 20 years of experience managing the preclinical and early clinical development of novel compounds under strategic alliances with public and private companies in Europe, the USA, and Asia.